These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18472986)

  • 21. Herpes Zoster Ophthalmicus: Presentation, Complications, Treatment, and Prevention.
    Litt J; Cunningham AL; Arnalich-Montiel F; Parikh R
    Infect Dis Ther; 2024 Jul; 13(7):1439-1459. PubMed ID: 38834857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Varicella-pox virus infection: features of the course, clinical manifestations, complications, and possibilities for prevention].
    Prikhodchenko NG
    Ter Arkh; 2021 Nov; 93(11):1401-1406. PubMed ID: 36286666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Herpes zoster and postherpetic neuralgia - prevention by vaccination?].
    Wutzler P
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S90-4. PubMed ID: 19353479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
    Holcomb K; Weinberg JM
    J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced Potency and Persistence of Immunity to Varicella-Zoster Virus Glycoprotein E in Mice by Addition of a Novel BC02 Compound Adjuvant.
    Li J; Fu L; Yang Y; Wang G; Zhao A
    Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.
    Freer G; Pistello M
    New Microbiol; 2018 Apr; 41(2):95-105. PubMed ID: 29498740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Varicella-zoster virus.
    Arvin AM
    Clin Microbiol Rev; 1996 Jul; 9(3):361-81. PubMed ID: 8809466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
    Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on varicella zoster virus vasculopathy.
    Nagel MA; Gilden D
    Curr Infect Dis Rep; 2014 Jun; 16(6):407. PubMed ID: 24819870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpes zoster vaccination.
    Kim KH
    Korean J Pain; 2013 Jul; 26(3):242-8. PubMed ID: 23861997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and molecular aspects of varicella zoster virus infection.
    Gilden D; Nagel MA; Mahalingam R; Mueller NH; Brazeau EA; Pugazhenthi S; Cohrs RJ
    Future Neurol; 2009 Jan; 4(1):103-117. PubMed ID: 19946620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel vaccine (Zostavax) to prevent herpes zoster.
    Holcomb K; Weinberg JM
    G Ital Dermatol Venereol; 2008 Apr; 143(2):119-23. PubMed ID: 18833038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The global epidemiology of herpes zoster.
    Yawn BP; Gilden D
    Neurology; 2013 Sep; 81(10):928-30. PubMed ID: 23999562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Oxman MN; Levin MJ; Johnson GR; Schmader KE; Straus SE; Gelb LD; Arbeit RD; Simberkoff MS; Gershon AA; Davis LE; Weinberg A; Boardman KD; Williams HM; Zhang JH; Peduzzi PN; Beisel CE; Morrison VA; Guatelli JC; Brooks PA; Kauffman CA; Pachucki CT; Neuzil KM; Betts RF; Wright PF; Griffin MR; Brunell P; Soto NE; Marques AR; Keay SK; Goodman RP; Cotton DJ; Gnann JW; Loutit J; Holodniy M; Keitel WA; Crawford GE; Yeh SS; Lobo Z; Toney JF; Greenberg RN; Keller PM; Harbecke R; Hayward AR; Irwin MR; Kyriakides TC; Chan CY; Chan IS; Wang WW; Annunziato PW; Silber JL;
    N Engl J Med; 2005 Jun; 352(22):2271-84. PubMed ID: 15930418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complications of varicella zoster virus reactivation.
    Nagel MA; Gilden D
    Curr Treat Options Neurol; 2013 Aug; 15(4):439-53. PubMed ID: 23794213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.
    Amlie-Lefond C; Gilden D
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1561-1569. PubMed ID: 27138380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination: a new option to reduce the burden of herpes zoster.
    Mick G
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccines for preventing herpes zoster in older adults.
    Gagliardi AM; Andriolo BN; Torloni MR; Soares BG
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD008858. PubMed ID: 26937872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging drugs for varicella-zoster virus infections.
    Andrei G; Snoeck R
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.